Neboglamine 10 mg — 60 oral research capsules. Neboglamine (CR-2249, also known as nebostinel) is a modulator of the glycine co-agonist site of the NMDA receptor, developed as a cognition-enhancing research compound and advanced through Phase II clinical investigation. Unlike direct NMDA agonists, it acts on the regulatory glycine site and potentiates receptor signalling only where endogenous glutamate transmission is already present — the same functional class as D-serine and D-cycloserine, but with an oral, small-molecule profile that makes it a practical tool compound for glutamatergic research.
RESEARCH USE ONLY · Not for human or veterinary use. For laboratory and collector purposes only.
Neboglamine is a small-molecule modulator of the glycine-binding site of the N-methyl-D-aspartate (NMDA) receptor, the principal mediator of slow excitatory neurotransmission and synaptic plasticity in the mammalian brain. In published preclinical work it restored NMDA-mediated signalling under pharmacological blockade and produced antipsychotic-like behavioural profiles in rodent models, without the sedative or cataleptic signature of dopamine-receptor antagonists [1]. Its activity has also been characterised in animal cognition paradigms, where glycine-site modulation is associated with enhanced learning and memory performance [3]. The compound reached Phase II clinical investigation and remains a reference tool for studying glycine-site pharmacology alongside D-serine and D-cycloserine [2]. No therapeutic or clinical claims are made or implied.
Primary Research Areas
NMDA receptor glycine-site modulation — the defining mechanism — studied for potentiation of NMDA-mediated signalling at the glycine co-agonist site, in the same functional class as D-serine and D-cycloserine [1,3].
Antipsychotic-model behavioural research — evaluated in PCP-induced hyperlocomotion and rearing paradigms in the rat, a standard preclinical screen for antipsychotic-like pharmacological activity [1].
Cognition and memory research — characterised in animal cognition paradigms for effects on learning and memory, consistent with the profile reported for glycine-site NMDA modulators [3].
Forebrain neuronal activation mapping — applied in Fos-like immunoreactivity studies mapping activation in the prefrontal cortex, nucleus accumbens and lateral septal nucleus [1].
Glutamatergic pathway pharmacology — used as a research comparator in work on glycine-binding-site stimulants and their influence on downstream dopaminergic signalling [2].
References
Chiusaroli R, Garofalo P, Espinoza S, Neri E, Caselli G, Lanza M. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat. Pharmacol Res. 2010;61(5):430–436.
Shimizu S, Sogabe S, Yanagisako R, Inada A, Yamanaka M, Iha HA, Ohno Y. Glycine-binding site stimulants of NMDA receptors alleviate extrapyramidal motor disorders by activating the nigrostriatal dopaminergic pathway. Int J Mol Sci. 2017;18(7):1416.
Lanza M, Makovec F. Cognition enhancing profile of CR 2249, a new NMDA-glycine site modulator. CNS Drug Rev. 1997;3(3):245–259.
Neboglamine (also known as nebostinel, CR-2249, or XY-2401) is an experimental small-molecule drug that acts as a positive allosteric modulator of the glycine site on the NMDA (N-methyl-D-aspartate) receptor. [1, 2]
How It Works
Target: It targets the glycine/co-agonist site of NMDA receptors in the brain. [1, 2]
Mechanism: It enhances NMDA receptor-mediated neurotransmission without directly binding to or over-activating the primary glutamate site, which helps avoid the toxicity risks of direct agonists. [1, 2]
Brain Activity: Preclinical studies in animals show it increases neuronal activation markers (such as Fos-like immunoreactivity) in key brain regions like the prefrontal cortex and nucleus accumbens. [1, 2]
Main Areas of Investigation
Schizophrenia: Studied as a potential treatment to help improve negative and cognitive symptoms by addressing NMDA receptor hypofunction. [1, 2]
Cocaine and Substance Dependence: Explored for its potential to help reduce relapse or manage toxicodependency related to stimulants and central nervous system sedatives. [1, 2, 3]
Cognition and Memory: Demonstrated memory- and cognition-enhancing effects in animal models, including reversing drug- or shock-induced cognitive deficits. [1, 2]
Why Limitless Biochem Shop?
Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.
Peptides, Nootropics, Amino acids…
Products tested by an independent laboratory
Exclusively pure compounds without additives
Worldwide Delivery
Warning
This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.
Avis
Il n’y a pas encore d’avis.
Soyez le premier à laisser votre avis sur “Neboglamine 10 mg – 60 capsules” Annuler la réponse
Avis
Il n’y a pas encore d’avis.